Re­call re­port: Apo­tex re­calls 2 batch­es of blood-thin­ner in­jec­tion af­ter sy­ringe mis­la­bel­ing sna­fu

Drug re­calls are an ug­ly busi­ness, par­tic­u­lar­ly be­cause they’re of­ten tied to drug­mak­ers mak­ing hard-to-miss mis­takes. In the case of Cana­di­an gener­ics mak­er Apo­tex, a la­bel­ing er­ror now has the FDA hard on its heels.

Apo­tex launched a vol­un­tary re­call of two batch­es of the blood thin­ner in­jec­tion enoxa­parin sodi­um this week af­ter dis­cov­er­ing that some sy­ringes were mis­la­beled and could’ve re­sult­ed in pa­tients ac­ci­den­tal­ly get­ting more of the drug than need­ed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER